Hokuyaku Takeyama Holdings,Inc. (SPSE:3055)

Market Cap	19.80B +10.6%
Revenue (ttm)	299.67B +4.5%
Net Income	1.96B -26.2%
EPS	93.16 -25.0%
Shares Out	21.02M
PE Ratio	10.11
Forward PE	n/a
Dividend	20.00 (2.17%)
Ex-Dividend Date	Mar 30, 2026

Volume	300
Average Volume	2,215
Open	942.00
Previous Close	923.00
Day's Range	942.00 - 942.00
52-Week Range	742.00 - 946.00
Beta	-0.01
RSI	58.61
Earnings Date	Feb 6, 2026

About SPSE:3055

Hokuyaku Takeyama Holdings,Inc. engages in the wholesale of pharmaceutical products and medical devices in Japan. It also sells medical devices, such as treatment and facility equipment, image diagnostic equipment, optical equipment, artificial organ-related equipment, bioinformation-related equipment, physical therapy equipment, and testing equipment, as well as general-purpose products, such as syringes to implants used in orthopedic surgery. In addition, the company operates pharmacies in Hokkaido and nursing care facilities; rents and sells...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2006
• Employees: 1,605
• Stock Exchange: Sapporo Stock Exchange
• Ticker Symbol: 3055

Financial Performance

In fiscal year 2025, SPSE:3055's revenue was 289.53 billion, an increase of 5.15% compared to the previous year's 275.36 billion. Earnings were 2.47 billion, an increase of 13.66%.